Komori
Tsubota Laboratory (4890) · InitiativeAdvanced

Expansion of the research collaboration framework within and outside Keio University

First written in FY2022. 9 of 11 entries say "Advanced", first in FY2023. Latest entry: 2026-08-12.

11entries
5years
6from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2022AdvancedFY2023 – 2026-05-012022: 120222023: 120232024: 220242025: 020252026: 72026
Same theme, other companies
Open Innovation Through Industry-Government-Academia Collaboration and Early CommercializationA theme 23 companies write about · 0 as a headwind · 23 as a tailwind

12 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 23 companies compared. The sentences above are computed from all 23.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「At the core of our R&D strategy, we have positioned our proprietary grant program, T-SBIR (Tsubota Small Business Innovation Research), based on the CCC concept, and are building an extensive domestic and international network with academia.」

    In addition to expanding joint research with universities and research institutions, we are developing a framework to identify research themes from academia in Japan and overseas and commercialize them using CCC and our proprietary T-SBIR grant program.
  2. FY2025-H1AdvancedAnnual report

    「The company becoming the first Japanese company to open an office in Eye Valley in Wenzhou, Zhejiang Province, the national center of myopia research in China, and its representative, Tsubota Kazuo (坪田 一男), becoming a visiting professor in the Department of Ophthalmology at Wenzhou Medical University」

    Regarding the expansion of its research collaboration platform beyond Keio University, the company disclosed the opening of an office in Wenzhou, Zhejiang Province, and the appointment of its representative, Tsubota Kazuo (坪田 一男), as a visiting professor in the Department of Ophthalmology at Wenzhou Medical University.
  3. FY2024AdvancedAnnual report

    「Keio Gijuku (Department of Orthopaedic Surgery, School of Medicine) Joint research agreement 1 April 2024 to 31 March 2025 Analysis of the mechanisms regulating aging through external light stimulation」

    The company newly disclosed a joint research agreement with the Department of Orthopaedic Surgery at the School of Medicine, Keio University, concerning the regulation of aging, expanding its areas of research collaboration.
  4. FY2023AdvancedAnnual report

    「The company has begun joint research not only with the School of Medicine at Keio University, but also with the School of Medicine at Juntendo University, the Faculty of Science and Technology at Keio University, Nagoya University and others.」

    Research collaboration with other universities and faculties to avoid dependence on the School of Medicine at Keio University has progressed from a policy objective to the launch of actual joint research projects.
  5. FY2022First statedAnnual report

    「Rather than relying solely on its relationship with the School of Medicine at Keio University, the company believes it is necessary to build a collaborative framework with universities that possess different technologies and can secure research facilities. It will move forward with joint research agreements with other universities and faculties, as well as endowed courses and other initiatives.」

    The company’s research platform is being directed away from dependence on a single university or faculty.
Moved together

"Strengthening basic research" moved the same way as this thread, in the same document, in 7 of its 11 moves.

744333★123456
  1. ★This thread
  2. 1Strengthening basic research7×
  3. 2Commercialization of R&D Pipelines and Establishment of Post-Launch Royalty Revenue4×
  4. 3Research and development on depression, dementia and other conditions using violet light4×
  5. 4Expanding partnerships with leading companies in Japan and overseas3×
  6. 5B2B model for commercializing research outcomes and intellectual property through partner companies3×
  7. 6Risk of Concentration among Major Shareholders and Declining Stock Liquidity3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Tsubota Laboratory yet. It last moved in the Earnings of 2026-08-12: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Expansion of the research collaboration framework within and outside Keio University | Tsubota Laboratory Incorporated (4890) | Komori